Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

From animal models to human disease: a genetic approach for personalized medicine in ALS.

Picher-Martel V, Valdmanis PN, Gould PV, Julien JP, Dupré N.

Acta Neuropathol Commun. 2016 Jul 11;4(1):70. doi: 10.1186/s40478-016-0340-5. Review.

2.

Defining SOD1 ALS natural history to guide therapeutic clinical trial design.

Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER, Lopate G, Pestronk A, Cudkowicz ME, Miller TM.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):99-105. doi: 10.1136/jnnp-2016-313521. Epub 2016 Jun 3.

PMID:
27261500
3.

Familial Amyotrophic Lateral Sclerosis.

Boylan K.

Neurol Clin. 2015 Nov;33(4):807-30. doi: 10.1016/j.ncl.2015.07.001. Epub 2015 Sep 8. Review.

4.

Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.

Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S, Kaspar BK, Svendsen CN.

J Neurosci. 2014 Nov 19;34(47):15587-600. doi: 10.1523/JNEUROSCI.2037-14.2014.

5.

Clinical neurogenetics: amyotrophic lateral sclerosis.

Harms MB, Baloh RH.

Neurol Clin. 2013 Nov;31(4):929-50. doi: 10.1016/j.ncl.2013.05.003. Review.

6.

Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:5-18. doi: 10.3109/21678421.2013.778548.

7.

Genetic overlap between apparently sporadic motor neuron diseases.

van Blitterswijk M, Vlam L, van Es MA, van der Pol WL, Hennekam EA, Dooijes D, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH.

PLoS One. 2012;7(11):e48983. doi: 10.1371/journal.pone.0048983. Epub 2012 Nov 14.

8.

Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis.

Song F, Chiang P, Wang J, Ravits J, Loeb JA.

J Neuropathol Exp Neurol. 2012 Feb;71(2):104-15. doi: 10.1097/NEN.0b013e3182423c43.

9.

Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, Mitsumoto H.

Neurology. 2009 Nov 17;73(20):1686-92. doi: 10.1212/WNL.0b013e3181c1dea3.

10.

Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Wang Q, Johnson JL, Agar NY, Agar JN.

PLoS Biol. 2008 Jul 29;6(7):e170. doi: 10.1371/journal.pbio.0060170.

11.

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S.

BMC Genomics. 2007 Jan 23;8:26.

Supplemental Content

Support Center